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ABSTRACT  Interferon  does not inactivate viruses or viral RNA. Virus  growth
is  inhibited  in interferon-treated  cells,  but  apart from  conferring  resistance  to
virus growth,  no  other  effect  of interferon  on  cells  has  been  definitely  shown
to take place.  Interferon  binds to cells even in the cold, but a period of incuba-
tion  at  370C  is  required  for  development  of  antiviral  activity.  Cytoplasmic
uptake  of  interferon  has  not  been  unequivocally  demonstrated.  Studies  with
antimetabolites  indicate  that  the  antiviral  action  of  interferon  requires  host
RNA  and  protein  synthesis.  Experiments  with  2-mercapto-l(f-4-pyridethyl)
benzimidazole  (MPB)  suggest  that an  additional  step  is  required between  the
binding  and  the  synthesis  of  macromolecules.  Interferon  does  not  affect  the
adsorption,  penetration,  or uncoating of RNA or DNA viruses,  but viral RNA
synthesis  is  inhibited  in  cells  infected  with  RNA  viruses.  The main  action  of
interferon appears to be the inhibition  of the translation of virus genetic informa-
tion probably by inhibiting the initiation of virus protein synthesis.
Interferon does not directly inactivate virus particles. It  blocks an intracellular
step  involved in virus  replication,  probably  virus-directed  protein  synthesis.
Interferon-treated  cells seem  to develop  this resistance  to viruses through an
active process involving cellular RNA and protein  synthesis. The mechanism
of action of  interferon  therefore  involves  the  following  two  distinct  prob-
lems: the changes which take place in an interferon-treated  cell that lead  to
the development  of resistance  to  virus growth,  and  how  events  in the virus
growth cycle  are modified by interferon treatment.
The noteworthy  properties of interferon  should be accounted  for by obser-
vations  on  its  mechanism  of  action.  These  properties  include  inhibition  of
DNA and RNA virus replication, a remarkable selectivity of interferon action
which results in inhibition of virus replication with as yet no detectable  effect
on  cell  metabolism,  the  variation  in  sensitivity  of  viruses  to  interferon,  its
species  specificity,  and  its remarkable  potency. What has been discovered  so
far about interferon  action does provide data which help to explain  some of
these properties.  At the end of this report I will try to show, at least provision-
ally, how current ideas on interferon action may explain some of its properties.
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LACK  OF  EFFECT  ON  UNINFECTED  CELLS
The  only  unequivocal  way  so  far  discovered  of demonstrating  an  effect  of
interferon  is by showing that interferon-treated  cells  are less  able to support
viral  growth than untreated  cells.  A few other responses  of the  cell  to inter-
feron  have  been  reported,  but  these  observations  were made with  crude or
only  partially  purified  preparations.  Obviously,  any  alterations  in  cellular
function  observed in interferon-treated  cells may be of relevance to the mech-
anism by which the antiviral  state is expressed,  but despite the importance  of
this approach, there have been few salient studies on the effect of interferon  on
cellular  metabolic activity, and all of these  studies have  had negative results.
The  reason  for  this  is  that  meaningful  results  can  only  be obtained  in this
case  with highly purified interferons.  Such work has failed to confirm  results
obtained  in  earlier  experiments  in which  crude  interferon  was  used.  Thus,
reports on an inhibition  of cellular  RNA  synthesis were not confirmed  when
highly purified interferon  was used  (1),  and effects on glucose metabolism  (2)
were  not  observed  with  purified material  (3).  Similarly,  purified  interferon
had  no effect on cell division  (4),  an action which had been reported earlier.
Furthermore,  cells  have  been  maintained  in  culture  and  passaged  con-
tinuously  exposed  to  interferon  for  prolonged  periods  without  apparent
deleterious  effects  (5,  6).
It  is clear that interferon  has no  gross effect  on cellular RNA  and protein
synthesis.  Because of the problem of impurities,  it is the negative results that
are  significant,  since  these were  obtained under  conditions where interferon
was  exerting  a  strong  antiviral  effect.  Thus,  if cellular  RNA  and  protein
synthesis  are involved in the  development  of resistance,  these are in  the syn-
thesis  of a specific  cell protein or RNA rather than in the over-all  amount of
RNA  and protein made.
THE  INTERACTION  BETWEEN  INTERFERON  AND  THE
CELL
Small amounts  of added interferon bind to the cell surface as a necessary pre-
lude  to the development  of antiviral  activity.  While this step  is necessary,  it
is not  sufficient  for the development  of antiviral  activity which  still  may be
blocked by an inhibitor of cellular RNA synthesis.
Chick cells incubated  with interferon at  1 °C for several  hours only develop
antiviral activity after a subsequent  incubation at 37°C following removal of
interferon  by  repeated  washings  (Table  I).  Addition  of  actinomycin  D
immediately  after the incubation at  1  C,  however,  blocked  the development
of antiviral  activity.  Therefore  a period  of incubation at 37°C is required for
appearance  of antiviral  activity  (7-10).  An  interaction  between  interferon
and the cell  does, however,  occur in the cold. When interferon was incubated
at 1  °C with cells which were then washed many times and incubated  at 37°C,
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the cells were found to develop  a degree of antiviral activity proportional  to
the concentration of interferon and the incubation time in the cold; however,
a  maximal  response  for  any concentration  was  reached  with  a  10-20  min
incubation.  These  results  suggested  that  an equilibrium  reaction  involving
interferon and a cell binding site might be taking place at 1  °C (Fig.  ).
In order to test whether this reaction involved the binding of interferon to a
superficial  site,  the cells were sequentially  incubated  with interferon  at 1 °C,
washed,  and  treated  at  1°C  with  a  concentration  of  trypsin  sufficient  to
destroy  any  interferon  accessible  to the  enzyme.  In  these experiments  anti-
viral activity failed to develop  (Table II). This result indicated that interferon
binds rapidly  and  firmly to superficial  sites  on cells  and  that this binding  is
necessary  for development of antiviral activity  (10,  11).  The binding site was
TABLE  I
EFFECT  OF  INCUBATION  AT  1
0C  ON  INTERFERON  ACTION
Virus titer (p.f.u.  X  10
-a
)
Treatment*  Initial incubation  Add.  7  hr at 37°C
None,  37°C  17  20
Interferon,  37C  1.8  1.2
None,  1°C  (+Act. D)  13  14  (15)
Interferon,  1°C  (+Act. D)  10  2.0  (14)
* Chick cells were incubated with 3 units of interferon  at 370 or 1°C. After 4
hr the cells were washed and immediately  infected with Semliki Forest virus
or incubated  an additional  7 hr at 37°C  with  or without  2  g/ml  of actino-
mycin D  (Act. D)  and then  infected. After 8 hr  of infection the infected cul-
tures  were frozen  and  thawed,  and the fluids were  assayed  for virus  yields.
Figures  in  parenthesis  are  the  results  in  experiments  performed  in  cells
treated with Act. D.
not  destroyed  by  treatment  of cells  with  trypsin  (Table  II)  or  with phos-
pholipase C (R. M. Friedman, unpublished observation).
It might  be logically  supposed  that  the next  step  would  involve  uptake
of interferon,  but  there  is no  convincing  experimental  evidence  that  entry
of interferon into the cell is also necessary for development of antiviral activity.
In early studies crude  interferon  seemed  to be  slowly removed from culture
fluids by cells (8,  12-14).  In later experiments with purified chick and mouse
interferons,  80%  of  the  interferon  initially  incubated  with  cells  was  not
detected  in culture fluids after 5 hr  (15),  but the disappearance  of interferon
from  the above described culture  fluids  was not  equivalent  to its  entry into
cells  since  purified  interferons  adsorb  nonspecifically  to  various  surfaces.
Also Buckler et al.  (16)  showed that less than 7%  of the interferon  incubated
with cells was removed  from the culture fluids in the course of the establish-
ment  of antiviral  activity.  Therefore,  considerable  uptake of interferon  was
not necessary  for  its  antiviral  action  to  develop.  However,  poly-L-ornithine
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which generally increases adsorption to and entry into cells of macromolecules
was reported to increase interferon action significantly (17).  This latter finding
suggests  that some  interferon  may enter  cells  and  that this  step  is  a second
prerequisite,  after adsorption, for interferon action.
Much information  is available on subsequent  steps which lead to the estab-
lishment  of the  antiviral  state in  interferon-treated  cells.  Unfortunately,  al-
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FIGURE  1.  Interferon-cell  interaction  at  1°C.
Chick  cells  were  incubated  with  various  con-
centrations  of  interferon  for  the  indicated
periods  of  time,  washed  six  times  with  cold
medium,  incubated  at 37C for  2  hr, and then
infected with  virus.  The virus  titer was assayed
on  chick  monolayers  by  a  plaque  technique
and  is  reported  as a percentage  of the titer on
control  cultures  which  had  not  received
interferon treatment.
TABLE  II
INHIBITION  OF INTERFERON ACTION  BY TRYPSIN TREATMENT
Treatment*  Virus titer  (p.f.u.  X  10-6)
None  18
Interferon  (1000 U/ml)  3.0
Trypsin  (3  mg/ml)  5.7
Trypsin  after interferon  5.2
Interferon  after  trypsin  1.2
* Chick  cells were incubated with  1000 U/ml of interferon for 20 min at  I °C.
After washing  they  were  treated with  3  mg/ml  of trypsin,  followed  by  soy-
bean trypsin inhibitor  (6 mg/ml),  and incubated at 37°C for 2  hr. The cells
were  then  infected with SFV,  and virus  yields after 8 hr were  assayed.
most  all of  this data  is  based  on findings  employing  potent  antimetabolites
(Table III),  and the use of such drugs involves  some  difficulties in that their
total effects on cells are not yet clearly understood. Nevertheless,  these studies
have  helped  to  clarify  some  aspects  of  the interferon-cell  interaction.  Spe-
cifically,  acquisition  of resistance probably  involves  synthesis  of  RNA  and
protein, and at least one other active function by the host cell.
Taylor  (18)  found  that  actinomycin  D,  which  inhibits  DNA-dependent
RNA  synthesis prevented  the development  of resistance  in response  to inter-
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feron.  The  reduction  in  single  cycle  yields  of  SFV  in  chick  embryo  cells
treated with interferon was not seen if the cells were treated with actinomycin
before  or together with interferon.  Moreover,  not only was virus production
greater  than in cells  treated with interferon  alone, but viral  RNA synthesis,
which  was markedly  depressed  by interferon,  was restored  to a near  normal
rate when actinomycin was added before interferon. Actinomycin added after
interferon  did not reverse well-established  resistance.  Thus, it  is the develop-
ment of resistance,  and not its expression,  that is  sensitive to actinomycin.  In
fact,  no  inhibitor of established  interferon  action has as yet been  discovered.
The findings with actinomycin have been repeatedly confirmed (19, 20), but
TABLE  III
ANTIMETABOLITE  INHIBITORS  OF  INTERFERON  ACTION
Site of action  References
RNA synthesis
1.  Inhibitors
Actinomycin D  (18,  19,  20)
6-Mercaptopurine  (23)
6-Azauridine  (22)
2.  Miscoding
5-Fuorouracil  (22)
Azacytidine  (R.  M. Friedman,  unpublished  observation)
Protein  synthesis
1.  Inhibitors
Puromycin  (19,  20,  24)
Cycloheximide  (23; R. M. Friedman,  unpublished observation)
2.  Amino  acid  analogues
Fluorophenylalanine  (25,  26)
DNA function
1.  Cross-linker
Mitomycin  C  (23)
2.  Thymidine  analogues
Iododeoxyuridine  (23)
5-Mercaptomethyl  uracil  (23)
the dose-response curve of actinomycin action on interferon  follows an unusual
pattern  in that a jump from zero to complete  inhibition  occurs  in a narrow
drug concentration range  (Fig.  2),  and it is possible that the effect of actino-
mycin  results  from  an  action  other  than its  suppression  of DNA  dependent
RNA  synthesis.  Indeed,  some  of the biological  effects  of actinomycin D  are
not easily  explained by a primary  effect on RNA synthesis only  (reviewed  in
reference  21).  However,  other  inhibitors  of  RNA  synthesis  with  different
mechanisms  of action have also been reported to block the antiviral action of
interferon  to  some  extent;  6-azauridine  which  inhibits  RNA  synthesis,  and
5-fluorouracil  which  is  incorporated  into  RNA  thereby  causing  miscoding,
both inhibit interferon  (22).  Two other RNA inhibitors,  azacytidine  (R.  M.
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Friedman,  unpublished  observation)  and  6-mercaptopurine  (23),  had  a
similar  effect.  The  results  obtained  with  these  drugs  were,  however,  not  as
impressive  as the findings with actinomycin.
Development  of  resistance  was  also  impaired  by  an  inhibitor  of protein
synthesis, puromycin (20, 24),  and by the amino acid analogue, fluorophenyla-
lanine  (25,  26).  As with actinomycin,  the time of adding these  inhibitors  in
relation  to interferon was important.  When puromycin  was added for 4  hr,
after  a  4  hr treatment  with interferon,  little  inhibition  of interferon  action
was observed  (24).  When  cells were  exposed  to interferon  for  1 hr and  then
incubated  for  a further 4 hr in  an interferon-free  medium  before challenge,
an  increase in resistance during this 4 hr period was observed.  This was not
FIouRE  2.  Effect  of  con-
centration  of  actinomycin
D  on  interferon  action.
Chick  cells  were  treated
with  the  indicated  con-
centration  of  actinomycin
D for 4 hr. They were then
incubated  with  10  U/ml of
interferon  for  2  hr  and
infected with Semliki Forest
virus. After 8 hr the cultures
were  frozen  and  thawed,
and  the fluids were assayed
for  virus.  Results  are  re-
ported as the  titer of virus.
0.01  0.03  0.Q  0.3  1.0
CONCENTRATION  OF  ACTINOMYCIN  D(/zg/ml)
seen,  however,  if puromycin  was  present  during  this  latter  period  (24).  In
the  same  study,  there  was  a  recovery  of  resistance  when  cells,  which  had
been incubated for a 5 hr period in the presence of interferon and puromycin,
were maintained for a further  20  hr after washing out the puromycin  before
virus challenge.  These results,  taken together,  suggest that a period of protein
synthesis  is required  after  exposure  to  interferon  for  resistance  to  develop.
Interesting  results  on  the  effect  of another  inhibitor  of protein  synthesis,
cycloheximide,  on development  of resistance  in mouse L cells were obtained
by Dianzani  et al.  (26).  Pretreatment  of cells with interferon  in the presence
of this inhibitor had no effect on the development  of resistance.  In  other cells,
however,  cycloheximide  was  effective  in  preventing  the  development  of
resistance  (23)  (F. Dianzani and R. M. Friedman, unpublished observations).
The effects of other metabolic  inhibitors  have been studied.  Mitomycin  C,
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iododeoxyuridine,  and  5-mercaptomethyl  uracil  inhibited  interferon  action,
while  5-fluoro-2'-deoxyuridine  did  not  (23).  The  latter  drug inhibits  DNA
synthesis,  while the others  have an additional  effect on the function of DNA,
either by causing cross-linking of DNA molecules  (mitomycin C) or by acting
as thymidine  analogues.  These results  indicate that functional  DNA as well
as RNA and protein synthesis are required for interferon action.
2-Mercapto-  (0/-4-pyridethyl)  benzimidazole  (MPB)  has also been shown
to  inhibit  interferon  action  (Fig.  3).  The  drug  has  no  effect  on  cell  RNA
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FIGURE  3.  MPB  effect  on  interferon  action  or  on  cell  protein  and  RNA  synthesis.
Chick  cells were incubated  with interferon  (100  U/ml) and  MPB. The  results are  re-
ported  as the percentage inhibition of growth by interferon as compared  with untreated
MPB-treated  control  cells.  Cells  were  also  incubated  in  the  presence  of  MPB  with
leucine-8H  or H332PO4 for 10 min  after 4 hr of previous MPB  treatment. The incorpora-
tion of these isotopes into protein or RNA, respectively,  in MPB-treated cells is reported
as a percentage of the specific activity  (cpm/,ug protein)  of control cells.
or protein  synthesis  in  concentrations  which  inhibit  interferon  action.  The
inhibitory  effect  on  interferon  action  was  reversed  by  simply  washing  the
cells.  MPB has  no  effect  on  established  interferon  action  or on  the binding
of interferon.  The site of MPB action would appear to be on a step following
interferon  binding  as  evidenced  by  the following  experiment  (Table  IV).
Cells were incubated  with interferon  at  1 C for  10 min or  1 hr. They were
then washed with cold medium,  MPB was added,  and the cells were warmed
to  370C  for 4 hr.  MPB  treatment  had  no  effect  on interferon  action  if the
incubation  at  1°C  was  permitted  to  proceed  for  1  hr,  but  its  action  was
blocked by MPB addition after a  10 min incubation at 1 C  (R. M. Friedman
and I.  Pastan,  manuscript in preparation).
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Evidence  for  a  step  following  binding but  before  RNA  and  protein  syn-
thesis  has  not  been  previously  reported,  although  an  investigation  of the
mechanism  of  action  of  polypeptide  hormones  has  revealed  an  analogous
picture. The action of thyroid-stimulating  hormone  (TSH) previously bound
to thyroid  cells was inhibited  by incubation with anti-TSH  antiserum if the
binding  reaction  had  been  allowed  to proceed  in  the  cold  for  5  min.  Little
effect of the antiserum was seen following a 1 hr incubation  (27).
MPB has also been shown to inhibit phospholipid synthesis. It is possible that
the step in interferon  action which is blocked by MPB involves phospholipids;
therefore,  among  possible  sites  for  this  step may  be  penetration  of cells  by
interferon,  induction of alterations  in membrane properties  by interferon,  or
induction  of  a new  protein by interferon.  It is  of interest  that the uptake of
nucleosides  in many cell lines (28),  and the induction of tyrosine transaminase
in  rat  cells  (G.  Tomkins,  personal  communication)  and  of  aryl  hydro-
TABLE  IV
MPB  INHIBITION  OF  INTERFERON  ACTION
FOLLOWING  A  10  MIN  INCUBATION
Treatment  SFV yield (p.f.u./0.2  ml)
1
°
for  10  min or  1 hr  37
°
for  4 hr  10 min incubation  1 hr incubation
None  None  72  X  105  58  X  105
None  MPB  (50  g/ml)  60  X  10
a 48  X  106
Interferon  (1000  U/ml)  None  80  X  104  33  X  104
Interferon  MPB  49  X  105  40  X  104
carbon  hydroxylase  in hamster  cells  (D.  Nebert,  personal  communication)
are  also  blocked  by MPB.  All of these actions may be membrane-associated
phenomena.
The current  concept  of how  interferon  brings  about  an  antiviral  state  in
cells is summarized  in Fig. 4.  Interferon  is bound to the cell membrane.  This
action may be reversed  by trypsin treatment.  A step follows which is the site
of inhibitory  action by MPB.  This may  involve  entry of interferon  into  the
cytoplasm.  Cell RNA and protein synthesis then appear to be required.  These
are  blocked  by,  among  other  inhibitors,  actinomycin  D and  puromycin  or
fluorophenylalanine,  respectively.  One possibility  is  that the actual antiviral
activity may be the result of inhibition of viral protein  synthesis caused  by a
specific  cell  protein.  Evidence  that viral  protein  synthesis  is  indeed  the  site
of interferon  action is presented in the following  section.
Site of Antiviral Action
The  observations just  described  provide  no  information  about  which  stage
in the virus growth cycle  is inhibited in the interferon-treated  cell.  To investi-
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gate this, detailed  biochemical  studies  have been  performed  on the effects of
interferon  on  events  taking  place  within  the-cell  during  the  replication  of
RNA  and DNA viruses.
DNA  Viruses
Most  of the  work  investigating  the  antiviral  action  of  interferon  in DNA
virus  replication  has  employed  vaccinia  virus  in  chick  or  mouse  cells  as
a test system.  Vaccinia  is a large virus with a complex  internal structure con-
taining DNA,  lipids, and structural  proteins.  Some of the structural  proteins
of the  virion  are functional  including  a  viral  DNA-dependent  RNA  poly-
merase  (29,  30).
Preliminary uncoating  of vaccinia virus takes place in the cytoplasm where
EXTRACELLULAR  CELL  MEMBRANE  INTRACELLULAR
interferon  bound
interferon  - at cell  membrane
(1)
intracellular  cell  RNA  cell  protein
L  interferon  _synthesis  synthesis
(2)  (3)
hypothetical
antiviral protein
inhibition of viral
nrnotin  svnthsis
FIGURE  4.  Present  concept  of  the  mechanism  of  interferon  action.  Action  may  be
blocked  by  (1)  trypsin,  after  adsorption of interferon;  (2) actinomycin  D; or  (3) puro-
mycin D; or  (3) puromycin  or fluorophenylalanine  before  addition of interferon.
all events  in the viral replication  cycle appear to occur  (31).  This step takes
place normally in interferon-treated  cells  (32). The complete uncoating of the
viral nucleocapsid is a complex process which is partially blocked in the inter-
feron-treated cell  (32). This step  involves the elaboration of a messenger RNA
by  the polymerase  of the virus  particle.  This  messenger  RNA codes  for  the
formation  of an uncoating  enzyme which releases  the genome  of the virion.
Thus,  the parental  genome  is  freed  for  subsequent  steps in  the replication
process.  Virus-directed  protein  synthesis  is  therefore  important  for the  final
uncoating of the genome  (33); however,  transcription of the parental genome
can  take  place  before  complete  uncoating  of  the virus.  In fact,  it has  been
shown that in  the absence  of protein  synthesis,  transcription  of the parental
genome  takes  place in an uncontrolled  manner leading  to increased  produc-
tion of viral messenger  RNA  (34).
In an extensive study of the effect of interferon  on vaccinia virus replication
157 sPURIFICATION  AND  MECHANISM  OF  ACTION
in mouse L cells, Joklik and Merigan  (35)  found an inhibition  of DNA poly-
merase and of viral DNA production in interferon-treated  cells. Paradoxically,
they  reported  that the  production  of viral  messenger  RNA  was  increased,
and, although the half-life  of the viral messenger  RNA was unaltered,  it did
not combine with ribosomes  to form polyribosomes.  In  fact, a disaggregation
of host  cell polyribosomes  had taken  place, and interferon-treated  cells were
almost devoid of both host and viral polyribosomes.  Marked  cell  destruction
was noted in the interferon-treated  cells. They  (35)  therefore concluded  that
a large amount  of vaccinia  virus messenger RNA  was produced but was not
translated  in  interferon-treated  cells  and  that  the  mechanism  of  action  of
interferon  was on a step between transcription  and translation of virus genetic
information.
Subsequent studies have confirmed  the conclusions  of Joklik and Merigan
(35)  and  served  to  explain  some  of their puzzling  findings.  An  RNA  poly-
merase  is  now known to be  a structural  element  of the  virion  (29,  30),  and
its  production  of viral RNA  is increased  in the  absence of viral  protein syn-
thesis  (30).  In the  interferon-treated  cell,  therefore,  the  uncontrolled  tran-
scription of parental DNA can be explained. The inhibition of cellular protein
synthesis can be accounted  for  as  this is due to another structural  element of
the virion (36).  Since the uncoating protein appears to be a virus product, its
synthesis would  be expected  to be blocked in interferon-treated  cells and as a
consequence  of this,  final  virus  uncoating  inhibited.  Most  of the viral  DNA
does remain within the nucleocapsid in interferon-treated  cells (32).
The mechanism  of action of interferon  on the early steps in vaccinia virus
replication  is shown  in Fig.  5.  The virus enters the cell  (Fig.  5,  2) and loses
its outer coat (Fig.  5, 3). The nucleocapsid which remains (Fig. 5, 4) produces
vaccinia  virus messenger  RNA since  a viral polymerase  is present within the
core structure  (Fig. 5,  5).  Vaccinia messenger RNA then forms polyribosomes
with cellular ribosomes (Fig.  5,  6).  A step between Fig.  5, 5 and  Fig. 5,  6 is
blocked  in interferon-treated  cells since  viral polyribosomes  do  not form.  In
normal  infection  a  viral  protein  is  produced  (Fig.  5,  7)  which uncoats  the
viral  nucleocapsid  (Fig.  5,  8) to release  viral DNA  (Fig. 5,  9).  In  the inter-
feron-treated  cell,  vaccinia  messenger  RNA  accumulates,  and  the  DNA
remains within nucleocapsids.
The effect  of interferon  on  the  activity of another  DNA virus,  SV40,  has
been extensively  studied.  The  transformation  of the  3T3  line of mouse cells
(37)  and  the  production  of  SV40  neoantigen,  T  antigen,  are  inhibited  by
interferon  (38).  In  the case of cells already transformed  by SV40,  however, T
antigen production is unaffected  by interferon  treatment.  The cells,  however,
remained  sensitive  to interferon  (5).
Important  studies  were  also  performed  on  an  adenovirus-SV40  hybrid.
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Adenoviruses  are much less sensitive to interferon  than are SV40 replication
and T antigen production  (39),  and in interferon-treated  cells coinfected with
both SV40  and adenovirus  7,  T antigen production  by SV40 was inhibited
(40).  In  cells  infected  with  the  adenovirus-SV40  hybrid  virus,  however,  T
antigen production was insensitive to interferon pretreatment (40).  Therefore,
in two situations the sensitivity to interferon  pretreatment  of SV40-T antigen
production  was altered.  In one case this was found in cells with a portion of
the SV40 DNA probably integrated  into the host genome  (39); in the other,
it was  found  in cells  with  a portion .of the  SV40  DNA  integrated  into  the
genome of an interferon-insensitive  virus  (40).
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FIGURE  5.  Inhibition of vaccinia  virus  growth  by interferon.  Extracytoplasmic  virus
(/)  enters the cytoplasm (2) where the outer coat is removed  (3).  Viral messenger RNA
is produced  (4). The messenger RNA  (5) interacts with ribosomes to form polyribosomes
(6) which produce an enzyme  (7).  The  enzyme  acts to uncoat the core of the virus  (8)
yielding free viral DNA (9).
RNA  Viruses
The best  understood systems  employing RNA  viruses  for the study  of inter-
feron  action  are  the growth  of the Group  A  arbovirus  Semliki  Forest  virus
(SFV)  in chick cells  and of mengovirus  in mouse cells.  All  studies agree  that
the primary site of interferon  action is  on an early event  in the virus replica-
tion cycle.
After  adsorption  and penetration  the single-stranded  RNA  of both viruses
is released  (Fig.  6,  3). The input viral RNA must immediately act as a genetic
messenger  (Fig.  6,  4)  since  no  RNA-dependent  RNA  polymerase  exists  in
the host cells or in the virions.  The production  of the viral RNA  polymerase
is the key  event in the early steps  of virus replication  (Fig.  6,  5).  Once  this
enzyme  is produced  a complementary  or negative strand  of viral  RNA can
be formed  (Fig.  6,  6). The viral  polymerase  uses the  negative strand  of viral
RNA  as a  template  to  turn  out  strands  of progeny  viral  RNA  (Fig.  6,  8)
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During this process  a partially double-stranded  RNA  complex is formed due
to the displacement from the duplex  of completed viral RNA forms by newly
initiated RNA strands  (Fig.  6,  7).
Progeny RNA  can  serve  one  of at least  three  functions:  it may be incor-
porated  into  virions,  or it may  serve  as  a messenger  RNA  form coding for
structural  and  functional  viral proteins,  or it may  act  as  a template for  the
production of additional negative strands.  Initiation of viral RNA replication
is  therefore  dependent  both  on translation  of input RNA  to form  an RNA
polymerase,  and  on  the  activity  of this  enzyme  in  transcribing  the RNA.
Which of the early  steps in virus replication is blocked by interferon?  Virus
adsorption  is unaffected  (41-43).  The dissociation  of viral RNA from its pro-
tein  coat  is  not  impaired  in  the  interferon-treated  cell  since  virus  growth
following infection with uncoated viral RNA is also inhibited (44). This means
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FIGURE  6.  Inhibition  of RNA virus growth by interferon.  Extracytoplasmic  virus  (I)
enters  the  cytoplasm  (2)  and is uncoated  to release  free  viral RNA,  the parental  (+)
strand  (3).  This  RNA  interacts with  ribosomes to form polyribosomes  (4)  which  form
a viral polymerase. The polymerase with the (+)  strand (5)  form a double-stranded RNA
form which is base paired, a (+)  and a (-)  strand (6).  New strands are formed using the.
(-)  strand as  a template  (7).  The progeny  RNA  is  released from the template  (8).
that the sensitive step in the growth cycle of RNA viruses is beyond the adsorp-
tion,  penetration,  and  uncoating  stages  (after  step  3, Fig.  6).  Inhibition  of
progeny viral RNA synthesis in interferon-treated cells has been demonstrated
in several  systems  (45-47).  The formation of all classes  of SFV RNA in chick
cells was also found to be depressed by treatment with high titers of interferon.
This included the production  of a ribonuclease-resistant  viral replicative form
(48).  Gordon et al.  (49),  made similar observations in the mengovirus-mouse
cell system.
In  addition  to  inhibition  of production  of progeny  viral  RNA,  interferon
treatment  blocks  the  synthesis  of virus-specific  proteins.  Production  of  the
polymerases  of both  SFV  (50)  and mengovirus  (51)  was  inhibited  in  inter-
feron-treated  cells.  As both studies were performed  late in infection,  most of
the  enzyme  produced  was  probably  made  by  translation  of progeny  viral
RNA. Since the production of progeny viral RNA was inhibited in interferon-
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treated  cells, it is likely that the observed inhibition of the polymerases  was a
consequence of the effect on viral RNA synthesis rather than being a primary
cause of inhibition  of virus replication.
Studies have therefore  focused  on the function of the parental  genome.  In
chick  cells treated with very  high titers of interferon radioactive  input SFV
RNA was not converted into a ribonuclease  resistant replicative form  (Fig. 7
A and D). This suggested that interferon-treated  cells did not produce strands
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FIGuRE  7.  Sucrose density  gradient analysis of RNA  extracted from cells infected with
32P-labeled  Semliki  Forest virus (SFV).  Actinomycin D-treated  (0.5 jg/ml) monolayers
containing  about  5  X  107  chick  embryo  fibroblasts  were  infected  with 8 2P-SFV  at  a
virus-cell multiplicity of 80:1.  RNA  was extracted with 5 % SDS; 0.4 ml of the extract
was  layered  over  a 6-30%  sucrose gradient  and sedimented  (3  hr  at  200,000 g  in an
SW50  rotor).  Extracts  were treated  with  ribonuclease  (1  /jg/ml, 10  min, 37C, 0.1  M
NaCI) before sedimentation  analysis.
of  RNA  complementary  to  the  parental  genome.  Therefore,  transcription
of the parental  RNA  did not  take place.  In  this respect  previous incubation
with  interferon  was  similar  to  treatment  with general  inhibitors  of protein
synthesis  such as puromycin and  cycloheximide  (Fig.  7 B and  C)  which  also
block  the  transcription  of  parental  viral  RNA,  presumably  by  inhibiting
the translation  of parental  RNA,  i.e.,  the  synthesis of  the viral  RNA  poly-
merase.
In  one respect,  however,  interferon  action does differ from that of general
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inhibitors  of  protein  synthesis.  In  SFV-infected  chick  cells,  parental  viral
RNA enters  into a  membrane-bound  replicative  complex  (RC)  which con-
tains  the replicating  forms  of the  viral  RNA  (Fig.  8  A).  Later  in infection
this  RC has been  shown  to contain  the viral  RNA  polymerase  (52).  Cyclo-
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FIGURE  8.  Difference in effect  of cycloheximide  or interferon  on parental viral RNA.
Chick cells pretreated for 2 hr with 0.5  jug/ml of actinomycin D were infected with SFV
which had been prepared in the presence  of uridine-3H.  After 1 hr of infection,  the cells
were  washed, and  mitochondrial  fractions were  prepared from  them. These  were then
layered  over discontinuous  15-60%  sucrose  gradients  (52)  and sedimented  for  1 hr at
200,000  g. Fractions  were  collected  and  analyzed  for radioactivity.  A,  No  treatment;
B, interferon, 500  U/ml for  14 hr before infection;  C, cycloheximide  100  /ig/ml present
during the  1 hr of infection.
heximide treatment inhibits entry of viral RNA into this complex  (Fig.  8 C).
On the other hand,  treatment with interferon  has no effect on the association
of parental viral RNA with the RC (Fig.  8 B); however,  only single-stranded
viral RNA is found in association  with the RC under these conditions  (R. M.
Friedman and T.  Sreevalsan,  data  in preparation)  as  the  replicating  forms
cannot be produced  in interferon-treated  cells  (Fig.  7  C).
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It  was of interest  to  determine  directly whether  interferon  treatment had
any inhibitory  effect on the translation  of the input RNA virus genome.  At
least  five  virus-specific  proteins  could  be  detected  by  polyacrylamide  gel
electrophoresis  in the cytoplasm  of SFV-infected chick  cells  (Fig. 9). Two  of
these  proteins  were  clearly  structural  proteins  of  the  virion  (53),  and  syn-
thesis of these proteins  by parental viral  RNA was observed  in infected cells
incubated at 37° (Fig. 9) or 42°C (Fig.  10). At 420C viral RNA synthesis was
FIGURE  9.  Polyacrylamide  gel  electrophoresi
of interferon-treated and control cell cytoplasmic
extracts.  Chick  cell  monolayers  were  treated
with  1,000  units  of  partially  purified  chick
R  n  I o  1  I  'neec11  a
mintereron  per  mnu  or  1  hr.  nese  cells  and
untreated  controls  were  treated  with  actino-
mycin  D  (2  /Ag/ml)  and  were infected  in  the
presence  of guanidine  (3  mg/ml).  After  4  hr,
the  cells  were  washed,  and 10  /ACi of a  amino
acid-' 4C mixture per ml was added in otherwise
amino acid-free medium. After 1 hr, cytoplasmic
extracts  were  prepared.  olyacrylamidce  gel
electrophoresis  was  performed  on  50-150-/1
samples  of  these  extracts  containing  about
20,000  cpm. After the run, the gels were  sliced
and  stained;  radioautography  was  performed
with  dehydrated  gel  slices.  Microdensitometer
scans  were  made  on  the  radioautograms:  A,
infected  cells,  no  interferon  treatment;  B,
infected  cells,  interferon  treatment;  C,  extract
of  cytoplasm  of uninfected  chick  cells  treated
with  actinomycin  D  and  guanidine.  Film  was
exposed  to  the  dehydrated  gels  for  7  days
(A,  C) or  14 days  (B). Longer exposure did not
reveal  additional  lines.  Arrows  indicate  the
cathodal  end  of  the  gel.  All  densitometer
tracings  shown  in  this study  are  direct photo-
graphs  of the original tracings.
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FITURE  10.  Polvacrvlamide  grelelectronhoresis
of interferon-treated  and control cell cytoplasmic
Cxruacts.  mICK (XcelS Were Lreateu  wiLe  merLerCon
and were  then infected.  The cells were  labeled
at 42C for I hr. Extracts were made and run on
polyacrylamide  gels;  the  radioautograms  pre-
pared from the gels were scanned  as previously
described.  A,  Incubation  for  I hr  at 42C, no
interferon  treatment;  B,  treated  with  1,000
units  of interferon  per ml  before  infection and
incubated  for  1  hr  at  42C  after  guanidine
reversal.
inhibited  by 87% (Table V).  This treatment, however,  had little effect on the
amount  of virus  protein  made  early  in  infection.  That  similar  results  with
respect  to virus  protein synthesis were  obtained  at both 370  and 42°C there-
fore  indicates  that the bulk of early  viral protein synthesis  is directed  by the
parental  genome.  In interferon-treated  cells  no virus-specific  proteins  could
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be  detected  at 370  (Fig.  9)  or at 42°C  (Fig.  10).  This  result  indicates  that
parental viral RNA is not translated in interferon-treated  cells (54).
The in vivo studies of Levy and Carter  (55)  have suggested  that the anti-
viral state results from an alteration of 40S ribosomal  subunits in interferon-
treated  cells  so  that they  cannot interact with input viral  RNA.  At 30  min
after infection some radioactive input viral RNA sedimented  at 50S in sucrose
gradients.  This  peak  was  absent  in  gradients  made  from  extracts  of  cells
treated  with  interferon  before  infection.  Later  in  infection  in  controls,  a
decrease  was  noted  in the number  of counts present  in  the  50S  component
and  an  increase  in  those  associated  with  a  240S  component;  the  latter  is
thought  to  represent  viral  polyribosomes.  In  interferon-treated  cells  some
240S  component  was  present,  but  still  no  50S  component  was  seen.  The
authors  concluded  that the  50S  complex  was due  to  an interaction  of viral
TABLE  V
EFFECT  OF  INCUBATION  AT  42°C  ON  VIRAL  RNA  AND
PROTEIN  SYNTHESIS
Specific  activity
Incubation  temp.  RNA  Protein
°C  cpm/g protein
37  15.9*  12.1
42  2.0  18.8
* Actinomycin  D-treated  (2  tAg/ml)  cells  were  infected  with  virus  in  the
presence of guanidine (3  mg/ml).  After washing,  the cells were incubated for
30 min at 37 ° or 42°C in Eagle's medium. The cells were then pulse labeled for
10  min with  10 FCi of uridine-3H  or leucine-3H  per ml. Total  protein and
acid-precipitable  radioactivity  were then determined.
RNA  with a 40S ribosomal  subunit,  that this was necessary  to form a func-
tional polyribosome, and that interferon treatment prevented  this interaction.
The nature of the 50S complex  was not, however,  clearly established,  and to
this reviewer  it remains  an  open question  whether  the ribosomal  subunit  is
the primary site of the interferon  action.
The  results  of  studies  of interferon  action  on  RNA  virus replication  are
summarized  in  Fig.  6.  They  suggest  a block  between  steps  3 and  4.  While
this seems to specify a distinct site of action,  it really does not since this is the
step  which involves  initiation  of animal virus  protein  synthesis  about  which
very little is known.
Results of studies in cell free systems will be discussed by Dr.  Sonnabend in
the following report.
DISCUSSION
Studies on the development of resistance to virus infection following interferon
treatment  clearly establish at least three distinct cellular  activities which are
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required  for  this  activity.  Interferon  binding  to  the  cell  must  take  place.
Work  with  MPB  implies  a  requirement  for  a  step  after  binding,  perhaps
involving  entry  of  interferon  or  modification  of  the  cell.  The  third  step  is
cellular macromolecule  synthesis. Data on the requirement for RNA synthesis
seem quite  convincing,  but,  as discussed below,  the requirement  for protein
synthesis is  not so  well established.
The particular species  of RNA required  for interferon  action  is not known.
Results from my laboratory with various doses of actinomycin D indicate that
a concentration  of 0.3  /ug/ml which completely  inhibits interferon  action  in
chick cells still permits some ribosomal RNA synthesis.  Taken together with a
report that puromycin  aminonucleoside  (which selectively  inhibits ribosomal
RNA  synthesis  [56])  had  no  effect  on  interferon  action  (23),  it would  seem
that ribosomal RNA is not the species required.  No data which would estab-
lish a requirement  for transfer RNA, messenger RNA,  or any other cell RNA
species are available.  It  is also not certain  that the species of RNA required  is
unique in the sense that it is induced by interferon  treatment.
Since the species of RNA which is required for interferon action is unknown,
it is  difficult  to  deliberate  on this  RNA's  function.  Reasonable  speculation
about this  problem is  closely related to the question of whether interferon  is
taken  up  by cells.  If interferon  acts  from  an external  location  (presumably
its site of attachment  on the plasma membrane)  certain  possible mechanisms
of interferon  action would be unlikely.  For instance,  the RNA form required
for interferon action  could be employed  to transport  interferon  into  the cell
or  to  modify  it  once  there;  however,  the  liklihood  of  these  possibilities  is,
of course, nil if interferon  acts from an extracytoplasmic  position.
The data on the requirement for cell protein synthesis for interferon  action
are not as convincing  as those  establishing the need for RNA  synthesis by use
of actinomycin  D. This is because one must reverse  the inhibition in order to
permit virus growth.  Also the dose of inhibitor  used must  not block cellular
RNA  synthesis,  a condition which has been met in only a few reports.  How-
ever,  even if these conditions are fulfilled,  a direct need for a protein per se is
not  necessarily  established.  For  instance,  cycloheximide  has  little  effect  on
ribosomal  RNA  synthesis  but does  inhibit the formation  of ribosomes,  pre-
sumably  by blocking  the synthesis  of a protein required  for their maturation
(57).  Thus,  one effect of an inhibitor of a protein synthesis might be to block
the formation of a ribonucleoprotein  or of an RNA species.
If  a protein is,  however,  required  for interferon  action,  a strong possibility
is that the species  of RNA  also required  is  the messenger  for that particular
protein.  A  model  for  the  development  of  the resistant  state  based  on  this
notion was suggested by Taylor  (18).  She proposed that interferon  acts as  a
derepressor;  therefore,  treatment of a cell  with interferon  would be followed
by synthesis  of a specific messenger RNA  directing the synthesis  of a protein-
possessing antiviral  activity.
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As will  be  discussed  in  detail  by Dr.  Sonnabend,  Marcus  and  Salb  (58)
suggested  that the  site  of action of this  postulated  antiviral protein  was  the
ribosome. The cellular antiviral protein was thought by them to interact with
the ribosome  to prevent  the synthesis  of viral  proteins  either  by preventing
the attachment  of the viral messenger  RNA  to ribosomes  or the translation
of the bound messenger  RNA. This work has many interesting implications,
far  beyond  its  possible  importance  in  uncovering  the  mechanism  of action
of  interferon.  It  is,  however,  based  on  the unproved  theory  of Taylor  that
interferon induces  a specific  new antiviral protein. Furthermore, experiments
by Kerr et al.  (59) and R. Z.  Lockart  (personal  communication)  have  so far
failed  to confirm  the findings  of Marcus and Salb  (57).  In addition,  E.  M.
Martin,  I.  M.  Kerr,  and J.  A.  Sonnabend  (personal  communication)  and
G. Bodo  (personal communication)  have  been unable  to obtain evidence  for
the association  of a newly  synthesized protein with ribosomes in cells treated
with interferon.  These  findings taken  together must bring  into question  the
proposals  of Marcus  and  Salb  (57).
With respect  to  the expression  of resistance  in  the interferon-treated  cell,
the  experiments  discussed  point  to  an  early  event  in  the  virus  replication
cycle  as  the  site  of action  of interferon.  It is evident that  interferon  has no
effect  on  steps  up  to  and  including  virus  uncoating  except  in  the  case  of
vaccinia  where  complete  uncoating  is related  to  virus  protein  synthesis.  It
also  seems clear that transcription of viral DNA occurs in interferon-treated
cells, but translation of viral RNA (input DNA in the case of single-stranded
RNA  viruses,  messenger  RNA  in the case  of DNA  viruses)  does not  occur.
Inhibition of other events in the virus replication cycle would appear to follow
as a consequence  of an inhibition of the translation of viral messenger  RNA.
The  basic  problem  in  understanding  interferon  action  is  therefore  how
interferon  blocks viral protein synthesis  and yet does  not seem  to effect  total
host  protein  synthesis  significantly.  The data  of Joklik  and  Merigan  (34)
indicate  that  virus messenger RNA does not combine with ribosomes to form
polyribosomes  in interferon-treated  cells.  This in turn means an inhibition of
the initiation  of virus protein  synthesis.  Since  this must be  a  very  complex
reaction,  I  would  like to  discuss  briefly the factors  which  are  obviously  in-
volved in order to arrive at what are reasonable guesses  as to the site of inter-
feron  action.  These  factors  include viral  messenger  RNA  and  cellular  ribo-
somes,  energy generating systems,  transfer  RNA forms,  and protein synthesis
initiation factors.
Of these, viral messenger  RNA must be involved.  In fact it is possible that
interferon  or some factor induced  by it is able  to interact or to modify viral
RNA  directly  and  thus  render  it  incapable  of combining  with  ribosomes.
No  modification  of cellular  constituents  would  then  be  required.  Findings
on infection with the adenovirus-SV40  hybrid and the SV40 transformed cell
are  of  considerable  interest  with  respect  to  this  hypothesis  (40).  Since  the
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synthesis  of an SV40 protein  normally inhibited  in interferon-treated  cells  is
not blocked in the above situation,  there can be nothing in the primary struc-
ture of the viral  messenger RNA  that prevents  its  translation  in interferon-
treated  cells.  Resistance  or sensitivity to  interferon  must therefore  be deter-
mined by such characteristics  of viral messenger  RNA as conformation  or the
nature  of  the  specific  regions  employed  for  attachment  to  ribosomes  and
initiation  of protein synthesis.
It is  of course  also  possible that interferon  causes  alteration  in one  of the
other factors  mentioned,  which in turn renders  it incapable  of reacting  pro-
ductively  with  viral  RNA.  Whatever  the modification  induced,  the  factor
must  still  be  capable  of being  employed  for cell  protein  synthesis.  Thus,  a
basic difference between viral and cellular messenger  RNA can  be exploited
to the detriment of the virus.
The energy  generating  systems  of the cell would seem  an  unlikely  site for
interferon action as it is difficult to conceive  of a method to make them avail-
able to the cell and not to the virus. Another possible site is on transfer RNA.
If the initiating  codons  of the virus  and  the cell  differ,  changes induced  by
interferon in transfer RNA forms involved in initiation might seriously inhibit
virus  protein  synthesis.  It is  also  possible  that  the  site  of  interferon  action
could  involve  a  chain  initiating  factor  for  protein  synthesis.  Very  little  is
known  yet  about  such  factors  in  animal  cells,  but  they  might  be  able  to
distinguish  between viral and cellular RNA.
The ribosome has been indicated by two laboratories to be the primary site
of interferon  action  (54,  57).  It is  possible  in  fact  that  an initiating  factor
acting  in  conjunction  with  a  ribosome  is  responsible.  Although  the experi-
ments  which  suggested  that  the  ribosome  is  the primary  site  of interferon
action  are  being  actively  discussed  at  present,  the  hypothesis  certainly  still
remains an attractive one.
At  any rate,  we  are  still  far  from  understanding  interferon  action  com-
pletely.  As a logical start in this direction  a cell-free system producing  bona
fide viral polypeptides will be necessary in order to dissect the factors required
for initiation of virus protein synthesis  and  to pick the  one directly involved
in interferon action.
From what has been uncovered  so far about interferon  action some reason-
able notions may be put forward to account for its properties. The inhibition
of a wide range of RNA and DNA viruses is  undoubtedly due to its effect  on
translation  of viral messenger  RNA. The selectivity  of interferon,  that is  the
ability  to  distinguish between  viral  and  host messenger  RNA's,  is  probably
due to basic differences between  these.  It is also possible,  though not fashion-
able, to account for this by postulating that virus protein synthesis proceeds by
a mechanism basically different from that of the host cell. Finally, it is possible
but also  unlikely  that interferon  action  is  selective  only in  the  sense that  it
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inhibits  the  initiation  of  all  new  protein  synthesis,  viral  and  cellular.  The
variation  in  virus  sensitivity  might  therefore  be  due  to  the  fact that  some
viral messenger RNA's resemble those of the cell more so than others, or that
protein synthesis in insensitive viruses is similar to that of the cell.
The species specificity of interferon  is most likely caused by factors relating
to the binding and possible entry  of interferon  or to  the ability  of interferon
to act as an inducer of a specific cell protein or modifier  of an already existing
cell element.  Finally,  the remarkable potency  of interferon could also be due
to an inducer or enzymatic function of interferon once processed in the proper
cell.
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